282 related articles for article (PubMed ID: 8390282)
21. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
Baird PN; Pritchard J; Cowell JK
Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
[TBL] [Abstract][Full Text] [Related]
22. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
23. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
Haber DA; Buckler AJ
New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
[TBL] [Abstract][Full Text] [Related]
24. Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome.
Santos A; Osorio-Almeida L; Baird PN; Silva JM; Boavida MG; Cowell J
Hum Genet; 1993 Aug; 92(1):83-6. PubMed ID: 8396067
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
26. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Genes Chromosomes Cancer; 1994 Jul; 10(3):183-9. PubMed ID: 7522041
[TBL] [Abstract][Full Text] [Related]
27. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.
Newsham I; Kindler-Röhrborn A; Daub D; Cavenee W
Genes Chromosomes Cancer; 1995 Jan; 12(1):1-7. PubMed ID: 7534105
[TBL] [Abstract][Full Text] [Related]
28. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors.
Bruening W; Gros P; Sato T; Stanimir J; Nakamura Y; Housman D; Pelletier J
Cancer Invest; 1993; 11(4):393-9. PubMed ID: 8324644
[TBL] [Abstract][Full Text] [Related]
30. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
[TBL] [Abstract][Full Text] [Related]
31. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
33. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
Reeve AE; Sih SA; Raizis AM; Feinberg AP
Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
[TBL] [Abstract][Full Text] [Related]
34. A developmental context for multiple genetic alterations in Wilms' tumor.
Feinberg AP
J Cell Sci Suppl; 1994; 18():7-12. PubMed ID: 7883796
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic abnormalities in mesoblastic nephroma: a link to Wilms' tumour?
Roberts P; Lockwood LR; Lewis IJ; Bailey CC; Batcup G; Williams J
Med Pediatr Oncol; 1993; 21(6):416-20. PubMed ID: 8390601
[TBL] [Abstract][Full Text] [Related]
36. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
Brown KW; Power F; Moore B; Charles AK; Malik KT
Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
[TBL] [Abstract][Full Text] [Related]
37. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
38. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
39. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
Radice P; Perotti D; De Benedetti V; Mondini P; Radice MT; Pilotti S; Luksch R; Fossati Bellani F; Pierotti MA
Genomics; 1995 Jun; 27(3):497-501. PubMed ID: 7558032
[TBL] [Abstract][Full Text] [Related]
40. Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare.
Royer-Pokora B; Ragg S; Heckl-Ostreicher B; Held M; Loos U; Call K; Glaser T; Housman D; Saunders G; Zabel B
Genes Chromosomes Cancer; 1991 Mar; 3(2):89-100. PubMed ID: 1648959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
